Weekly Analysts’ Ratings Changes for ARM (ARM)

A number of firms have modified their ratings and price targets on shares of ARM (NASDAQ: ARM) recently:

• 4/16/2026 – ARM had its price target raised by Susquehanna from $170.00 to $210.00. They now have a “positive” rating on the stock.
• 4/9/2026 – ARM had its price target raised by The Goldman Sachs Group, Inc. from $110.00 to $125.00. They now have a “sell” rating on the stock.
• 4/7/2026 – ARM had its “equal weight” rating reaffirmed by Morgan Stanley. They now have a $150.00 price target on the stock, up from $135.00.
• 4/6/2026 – ARM had its price target raised by Mizuho from $160.00 to $230.00. They now have an “outperform” rating on the stock.
• 4/1/2026 – ARM had its price target raised by Wells Fargo & Company from $165.00 to $175.00. They now have an “overweight” rating on the stock.
• 3/26/2026 – ARM had its “overweight” rating reaffirmed by Barclays PLC. They now have a $165.00 price target on the stock.
• 3/26/2026 – ARM was upgraded by Needham & Company LLC from “hold” to “buy”. They now have a $200.00 price target on the stock.
• 3/25/2026 – ARM had its “buy” rating reaffirmed by Rosenblatt Securities. They now have a $175.00 price target on the stock.
• 3/25/2026 – ARM had its price target raised by Royal Bank Of Canada from $130.00 to $175.00. They now have an “outperform” rating on the stock.
• 3/25/2026 – ARM had its price target raised by Deutsche Bank Aktiengesellschaft from $125.00 to $140.00. They now have a “hold” rating on the stock.
• 3/25/2026 – ARM had its price target raised by Wells Fargo & Company from $150.00 to $165.00. They now have an “overweight” rating on the stock.
• 3/25/2026 – ARM had its price target raised by Guggenheim from $201.00 to $240.00. They now have a “buy” rating on the stock.
• 3/25/2026 – ARM was upgraded by Raymond James Financial, Inc. from “market perform” to “outperform”. They now have a $166.00 price target on the stock.
• 3/20/2026 – ARM was upgraded by HSBC Holdings plc from “reduce” to “buy”. They now have a $205.00 price target on the stock, up from $90.00.

Insiders Place Their Bets

In related news, CEO Rene A. Haas sold 9,299 shares of the stock in a transaction on Tuesday, April 14th. The stock was sold at an average price of $160.85, for a total value of $1,495,744.15. Following the completion of the sale, the chief executive officer directly owned 273,680 shares in the company, valued at $44,021,428. This represents a 3.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Jason Child sold 21,280 shares of the stock in a transaction dated Wednesday, March 25th. The stock was sold at an average price of $148.37, for a total value of $3,157,313.60. Following the sale, the chief financial officer owned 174,706 shares of the company’s stock, valued at approximately $25,921,129.22. The trade was a 10.86% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 62,432 shares of company stock valued at $9,784,330 over the last 90 days.

Arm Limited (NASDAQ: ARM) is a global semiconductor IP company best known for designing energy-efficient processor architectures and related technologies that underpin a wide range of computing devices. Founded in 1990 as a joint venture between Acorn Computers, Apple and VLSI Technology and headquartered in Cambridge, England, Arm develops the ARM instruction set architectures and core processor designs that chipmakers license and integrate into custom system-on-chip (SoC) products. The company operates a licensing and royalty business model rather than manufacturing chips itself.

Arm’s product portfolio includes CPU core families (such as Cortex and Neoverse lines), GPU and multimedia IP (Mali), neural processing units (Ethos) and a suite of system and physical IP blocks.